CirritoJR, DisabatoBM, RestivoJL, et al.: Serotonin signaling is associated with lower amyloid-β levels and plaques in transgenic mice and humans. Proc Natl Acad Sci U S A, 2011; 108:14968–14973.
2.
CochetM, DonnegerR, CassierE, et al.: 5-HT4 receptors constitutively promote the non-amyloidogenic pathway of APP cleavage and interact with ADAM10. ACS Chem Neurosci, 2013; 4:130–140.
3.
NitschRM, DengM, GrowdonJH, WurtmanRJ: Serotonin 5-HT2a and 5-HT2c receptors stimulate amyloid precursor protein ectodomain secretion. J Biol Chem, 1996; 271:4188–4194.
4.
JasterR, SparmannG, EmmrichJ, LiebeS: Extracellular signal regulated kinases are key mediators of mitogenic signals in rat pancreatic stellate cells. Gut, 2002; 51:579–584.
5.
CrisafulliC, DragoA, SidotiA, SerrettiA: A genetic dissection of antipsychotic induced movement disorders. Curr Med Chem, 2013; 20:312–330.
6.
KimB, LeeJH, JinWJ, KimHH, HaH, LeeZH: Trapidil induces osteogenesis by upregulating the signaling of bone morphogenetic proteins. Cell Signal, 2018; 49:68–78.
7.
ZhouX, PardueMT, IuvonePM, QuJ: Dopamine signaling and myopia development: What are the key challenges. Prog Retin Eye Res, 2017; 61:60–71.
8.
KimMK, AungMH, MeesL, OlsonDE, PozdeyevN, IuvonePM: Dopamine deficiency mediates early rod-driven inner retinal dysfunction in diabetic mice. Invest Ophthalmol Vis Sci, 2018; 59:572–581.
9.
ArchibaldNK, ClarkeMP, MosimannUP, BurnDJ: The retina in Parkinson's disease. Brain, 2009; 132(Pt 5):1128–1145.
10.
RazeghinejadMR, NowroozzadehMH, EghbalMH: Levodopa and other pharmacologic interventions in ischemic and traumatic optic neuropathies and amblyopia. Clin Neuropharmacol, 2016; 39:40–48.
11.
GalvisV, TelloA, ParraMM, et al.: Topical atropine in the control of myopia. Med Hypothesis Discov Innov Ophthalmol, 2016; 5:78–88.
12.
Valentín-MendozaS, Nieves-NievesJ, Fernández-MederoR, Fernández-GonzalesR, Adorno-FontánezJ, Adorno-FontánezE: Pulmonary lymphangioleiomyomatosis: literature update. Bol Asoc Med P R, 2013; 105:64–69.
13.
FinlayGA, MalhowskiAJ, LiuY, FanburgBL, KwiatkowskiDJ, ToksozD: Selective inhibition of growth of tuberous sclerosis complex 2 null cells by atorvastatin is associated with impaired Rheb and Rho GTPase function and reduced mTOR/S6 kinase activity. Cancer Res, 2007; 67:9878–9886.
14.
HernándezC, BogdanovP, CorralizaL, et al.: Topical administration of GLP-1 receptor agonists prevents retinal neurodegeneration in experimental diabetes. Diabetes, 2016; 65:172–187.
15.
DietrichN, KolibabkaM, BuschS, et al.: The DPP4 inhibitor linagliptin protects from experimental diabetic retinopathy. PLoS One, 2016; 11:e0167853.
16.
OttC, RaffU, SchmidtS, et al.: Effects of saxagliptin on early microvascular changes in patients with type 2 diabetes. Cardiovasc Diabetol, 2014; 13:19.
17.
BallingerAB, WilliamsG, CorderR, El-HajT, FarthingMJ: Role of hypothalamic neuropeptide Y and orexigenic peptides in anorexia associated with experimental colitis in the rat. Clin Sci (Lond), 2001; 100:221–229.
18.
FatemiI, ShamsizadehA, RoohbakhshA, AyoobiF, SanatiMH, MotevalianM: Increase in mRNA level of Orexin1 and 2 receptors following induction of experimental autoimmune encephalomyelitis in mice. Iran J Allergy Asthma Immunol, 2016; 15:20–26.
19.
SongJ, KimE, KimCH, SongHT, LeeJE: The role of orexin in post-stroke inflammation, cognitive decline, and depression. Mol Brain, 2015; 8:16.
CalsavaraAJC, NobreV, BarichelloT, TeixeiraAL: Post-sepsis cognitive impairment and associated risk factors: a systematic review. Aust Crit Care, 2017; 31:242–253.
22.
Mendoza-TorreblancaJG, Vanoye-CarloA, Phillips-FarfánBV, Carmona-AparicioL, Gómez-LiraG: Synaptic vesicle protein 2A: basic facts and role in synaptic function. Eur J Neurosci, 2013; 38:3529–3539.
23.
ReisPA, AlexandrePCB, D'AvilaJC, et al.: Statins prevent cognitive impairment after sepsis by reverting neuroinflammation, and microcirculatory/endothelial dysfunction. Brain Behav Immun, 2017; 60:293–303.
24.
ZhangL, LohHH, LawPY: A novel noncanonical signaling pathway for the μ-opioid receptor. Mol Pharmacol, 2013; 84:844–853.
25.
ZhangL, ZhaoH, QiuY, LohHH, LawPY: Src phosphorylation of micro-receptor is responsible for the receptor switching from an inhibitory to a stimulatory signal. J Biol Chem, 2009; 284:1990–2000.
AppelCK, Gallego-PedersenS, AndersenL, et al.: The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain. Sci Rep, 2017; 7:4792.
28.
HanKE, ChoiSI, KimTI, et al.: Pathogenesis and treatments of TGFBI corneal dystrophies. Prog Retin Eye Res, 2016; 50:67–88.
29.
MaengYS, LeeGH, ChoiSI, KimKS, KimEK: Histone methylation levels correlate with TGFBIp and extracellular matrix gene expression in normal and granular corneal dystrophy type 2 corneal fibroblasts. BMC Med Genomics, 2015; 8:74.
30.
MimoriS, OhtakaH, KoshikawaY, et al.: 4-Phenylbutyric acid protects against neuronal cell death by primarily acting as a chemical chaperone rather than histone deacetylase inhibitor. Bioorg Med Chem Lett, 2013; 23:6015–6018.
31.
KimDS, LiB, RhewKY, et al.: The regulatory mechanism of 4-phenylbutyric acid against ER stress-induced autophagy in human gingival fibroblasts. Arch Pharm Res, 2012; 35:1269–1278.
32.
PiwnicaD, PathakA, SchäferG, DochertyJR: In vitro safety pharmacology profiling of topical α-adrenergic agonist treatments for erythema of rosacea. Drugs R D, 2018; 18:87–90.
ParnasH, SlutskyI, RashkovanG, SilmanI, WessJ, ParnasI: Depolarization initiates phasic acetylcholine release by relief of a tonic block imposed by presynaptic M2 muscarinic receptors. J Neurophysiol, 2005; 93:3257–3269.
35.
MelchiorreC, AngeliP, LambrechtG, MutschlerE, PicchioMT, WessJ: Antimuscarinic action of methoctramine, a new cardioselective M-2 muscarinic receptor antagonist, alone and in combination with atropine and gallamine. Eur J Pharmacol, 1987; 144:117–124.
36.
WrightMC, PotluriS, WangX, et al.: Distinct muscarinic acetylcholine receptor subtypes contribute to stability and growth, but not compensatory plasticity, of neuromuscular synapses. J Neurosci, 2009; 29:14942–14955.
37.
O'HernPJ, do Carmo G GonçalvesI, BrechtJ, et al.: Decreased microRNA levels lead to deleterious increases in neuronal M2 muscarinic receptors in Spinal Muscular Atrophy models. Elife, 2017; 6:e20752.
38.
LundquistI, PanagiotidisG, StenströmA: Effect of L-DOPA administration on islet monoamine oxidase activity and glucose-induced insulin release in the mouse. Pancreas, 1991; 6:522–527.
39.
LindströmP, SehlinJ: Mechanisms underlying the effects of 5-hydroxytryptamine and 5-hydroxytryptophan in pancreatic islets. A proposed role for L-aromatic amino acid decarboxylase. Endocrinology, 1983; 112:1524–1529.
